Timely diagnosis is the most important parameter for the detection and hindrance with tissues (infected). Many conventional techniques are used for the determination of the chronic disease like MRI, X-ray, mammography, ultrasound and other diagnosing methods. Nevertheless, they have some limitations.
View Article and Find Full Text PDFClin Psychopharmacol Neurosci
February 2021
Major depressive disorder (MDD) is a heterogeneous disease which is why there are currently no specific methods to accurately test the severity, endophenotype or therapy response. This lack of progress is partly attributed to the com-plexity and variability of depression, in association with analytical variability of clinical literature and the wide number of theoretically complex biomarkers. The literature accessible, indicates that markers involved in inflammatory, neuro-trophic and metabolic processes and components of neurotransmitters and neuroendocrine systems are rather strong indicators to be considered clinically and can be measured through genetic and epigenetic, transcriptomic and proteomic, metabolomics and neuroimaging assessments.
View Article and Find Full Text PDFBackground: The use of herbal/ herbal products has increased from more than a decade. Other than increasing the safety and efficacy of these products, the public needs to be aware of the possible interactions that could occur when combined with conventional drug therapy. Despite the lack of sufficient information on the safety of herbal products, their use as an alternative and complementary medicine is globally widespread.
View Article and Find Full Text PDF